Last updated on September 2018

A Study of ELIGARD in Hormone-dependent Prostate Cancer Patients

Brief description of study

The objective of this study is to evaluate the safety, efficacy, and impact on quality of life (QoL) of ELIGARD in hormone-dependent prostate cancer patients in Asia.

Clinical Study Identifier: NCT03035032

Contact Investigators or Research Sites near you

Start Over

Astellas Pharma Inc.

Site HK01002
Hong Kong, Hong Kong

Astellas Pharma Inc.

Site HK01001
Hong Kong, Hong Kong

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.